financetom
Business
financetom
/
Business
/
Xcel Energy Q4 Ongoing Earnings, Operating Revenue Fall; 2025 Ongoing EPS Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Xcel Energy Q4 Ongoing Earnings, Operating Revenue Fall; 2025 Ongoing EPS Outlook Set
Feb 6, 2025 3:52 AM

06:28 AM EST, 02/06/2025 (MT Newswires) -- Xcel Energy ( XEL ) reported Q4 ongoing earnings Thursday of $0.81 per diluted share, down from $0.83 a year earlier.

Analysts polled by FactSet estimated $0.87.

Operating revenue for the quarter ended Dec. 31 was $3.12 billion, compared with $3.44 billion a year earlier.

Analysts surveyed by FactSet expected $3.77 billion.

Xcel Energy ( XEL ) said it expects 2025 ongoing EPS in the range of $3.75 to $3.85. Analysts polled by FactSet expect $3.82.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rome's 'Hollywood on the Tiber' plans comeback despite Trump tariff threat
Rome's 'Hollywood on the Tiber' plans comeback despite Trump tariff threat
May 31, 2025
ROME (Reuters) -Europe's largest film studio Cinecitta is aiming to re-launch Italy as a movie powerhouse, even as U.S. President Donald Trump's proposed tariffs on foreign productions cast a shadow over the film industry globally. Cinecitta, the homonymous company that manages Rome's historic film studio, approved a five-year plan this week backed by the EU's post-COVID Recovery Fund, which includes...
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
May 31, 2025
* Trodelvy/Keytruda patients had 11.2 months progression-free survival vs 7.8 months for chemotherapy/Keytruda * ASCO says Trodelvy/Keytruda likely to become standard of care * Patients still being followed to see if combination extends survival By Deena Beasley May 31 (Reuters) - Gilead Sciences' ( GILD ) Trodelvy in combination with Merck's ( MRK ) blockbuster immunotherapy Keytruda lowered the risk...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
OPEC+ set to discuss July oil output hike, may be larger than 411,000 bpd, sources say
OPEC+ set to discuss July oil output hike, may be larger than 411,000 bpd, sources say
May 31, 2025
LONDON/MOSCOW (Reuters) -OPEC+ meets on Saturday to discuss an increase in oil output for July that may be larger than the 411,000 barrels per day (bpd) increases it made for May and June, sources familiar with OPEC+ talks told Reuters. Eight OPEC+ countries have been raising output more rapidly than earlier planned, even though the extra supply has weighed on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved